A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.

Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its ...

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

An online program called eSense appeared to be effective for the treatment of sexual interest/arousal disorder (SIAD) in women, according to new research. The program led to significant improvement in ...

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.

Low libido is a lack of sexual desire or interest. Orgasmic disorders cause difficulty achieving orgasm, even with enough arousal. Sexual arousal disorder includes problems with getting or staying ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...